home / stock / vicl / vicl quote
Last: | $ |
---|---|
Change Percent: | -15.68% |
Open: | $0.79 |
Close: | $0.676 |
High: | $0.91 |
Low: | $0.60 |
Volume: | 7,063,374 |
Last Trade Date Time: | 09/02/2019 04:50:51 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $0.79 | $0.676 | $0.91 | $0.60 | 7,063,374 | 09-02-2019 |
$ | $0.79 | $0.676 | $0.91 | $0.60 | 7,057,891 | 08-30-2019 |
$ | $0.8894 | $0.8017 | $0.915 | $0.777 | 3,041,599 | 08-29-2019 |
$ | $0.869 | $0.9015 | $0.93 | $0.8429 | 4,023,889 | 08-28-2019 |
$ | $0.85 | $0.8562 | $0.88 | $0.822 | 858,405 | 08-27-2019 |
$ | $0.845 | $0.85 | $0.87 | $0.79 | 772,936 | 08-26-2019 |
$ | $0.85 | $0.8159 | $0.85 | $0.79 | 670,304 | 08-23-2019 |
$ | $0.87 | $0.8425 | $0.893 | $0.8123 | 764,798 | 08-22-2019 |
$ | $0.8638 | $0.8699 | $0.91 | $0.8561 | 508,896 | 08-21-2019 |
$ | $0.85 | $0.8559 | $0.87 | $0.83 | 340,210 | 08-20-2019 |
$ | $0.87 | $0.845 | $0.8987 | $0.8316 | 678,155 | 08-19-2019 |
$ | $0.8035 | $0.87 | $0.92 | $0.8035 | 1,649,632 | 08-16-2019 |
$ | $0.7927 | $0.80 | $0.825 | $0.7901 | 444,010 | 08-15-2019 |
$ | $0.7936 | $0.8029 | $0.84 | $0.7403 | 880,841 | 08-14-2019 |
$ | $0.8099 | $0.7875 | $0.81 | $0.775 | 525,445 | 08-13-2019 |
$ | $0.80 | $0.7911 | $0.8092 | $0.781 | 591,701 | 08-12-2019 |
$ | $0.81 | $0.8048 | $0.8299 | $0.79 | 1,506,337 | 08-09-2019 |
$ | $0.8299 | $0.8057 | $0.8331 | $0.779 | 836,773 | 08-08-2019 |
$ | $0.78 | $0.8083 | $0.845 | $0.77 | 1,529,987 | 08-07-2019 |
$ | $0.70 | $0.7701 | $0.82 | $0.70 | 1,887,566 | 08-06-2019 |
News, Short Squeeze, Breakout and More Instantly...
Vical Incorporated Company Name:
VICL Stock Symbol:
NASDAQ Market:
Anti-retroviral therapy (ART), or highly-active-antiretroviral therapy (HAART), is effective in halting the progression of HIV infection (a disease affecting nearly 40 million persons worldwide). However, HAART does not cure the disease as the HIV virus, despite the treatment, remains hidden in ...
Anti-retroviral therapy (ART), or highly-active-antiretroviral therapy (HAART), is effective in halting the progression of HIV infection (a disease affecting nearly 40 million persons worldwide). However, HAART does not cure the disease as the HIV virus, despite the treatment, remains hidden in ...
• Merger Transaction Expected to Close August 31, 2019 SAN DIEGO, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Vical Incorporated (“Vical”) (Nasdaq:VICL) announced that its stockholders voted to approve the proposals required to complete the merger transaction with Bric...